SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

Historical Holders from Q1 2014 to Q3 2025

Symbol: SUPN on Nasdaq
Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 56,047,431
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 57,680,668
Holdings value: $2,756,395,707
% of all portfolios: 0.005%
Number of holders: 305
Number of buys: 146
Number of sells: -160
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	14.7%		$266,321,277		8,197,023		BlackRock, Inc.	31 Mar 2025
ARMISTICE CAPITAL, LLC	5.06%	-46.9%	$135,532,440	-$112,784,400	2,836,000	-45.4%	Armistice Capital, LLC	30 Sep 2025

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	57,680,668	$2,756,395,707	-$55,648,031		$11,162,358	$47.79	305
2025 Q2	59,473,450	$1,874,807,260	+$9,630,477	$0	$577,448	$31.52	292
2025 Q1	59,101,687	$1,935,404,930	-$15,482,554	$206,325	$288,200	$32.75	289
2024 Q4	59,487,720	$2,151,322,834	-$22,020,752	$216,960	$806,368	$36.16	289
2024 Q3	59,870,229	$1,866,730,333	+$55,809,134	$352,334	$863,686	$31.18	269
2024 Q2	58,408,045	$1,562,624,874	+$31,544,259	$350,425	$1,281,325	$26.75	241
2024 Q1	56,687,119	$1,933,242,340	-$13,205,166	$2,087,532	$2,868,651	$34.11	246
2023 Q4	57,120,264	$1,653,064,952	+$17,403,885	$654,044	$706,136	$28.94	244
2023 Q3	56,959,606	$1,570,365,603	-$13,068,601	$52,383	$606,540	$27.57	235
2023 Q2	57,192,976	$1,719,305,714	+$49,379,666	$342,684	$2,537,064	$30.06	244
2023 Q1	55,275,699	$2,002,621,195	-$15,673,429	$90,575	$2,883,408	$36.23	254
2022 Q4	55,885,167	$1,993,935,462	+$8,207,715	$7,134	$884,616	$35.67	259
2022 Q3	55,685,346	$1,884,907,309	+$24,605,478	$335,000	$1,026,000	$33.85	236
2022 Q2	54,730,295	$1,582,868,015	+$42,197,813	$257,000	$1,411,000	$28.92	214
2022 Q1	53,502,805	$1,728,247,579	-$41,233,819	$3,226,000	$3,364,000	$32.32	220
2021 Q4	55,217,286	$1,609,193,475	+$18,456,601	$3,143,000	$2,688,000	$29.16	226
2021 Q3	54,377,202	$1,451,011,413	+$3,672,754	$706,000	$5,823,500	$26.67	217
2021 Q2	54,148,773	$1,667,192,127	+$29,163,166	$1,774,000	$2,063,000	$30.79	222
2021 Q1	53,335,145	$1,397,017,874	+$13,336,729	$733,000	$3,288,000	$26.18	217
2020 Q4	52,923,548	$1,331,865,761	+$29,078,257	$1,223,000	$4,296,500	$25.16	219
2020 Q3	51,463,966	$1,072,432,929	+$15,343,379	$1,474,000	$485,000	$20.84	204
2020 Q2	50,545,295	$1,200,362,920	+$48,582,918	$344,000	$957,000	$23.75	213
2020 Q1	48,465,165	$871,862,986	-$52,617,228	$1,010,000	$1,012,000	$17.99	199
2019 Q4	51,308,069	$1,216,964,651	+$7,789,909	$2,583,000	$6,674,000	$23.72	230
2019 Q3	50,639,622	$1,391,452,892	-$78,862,126	$6,603,000	$9,593,000	$27.48	236
2019 Q2	52,880,406	$1,749,297,467	-$144,709	$8,258,000	$10,689,000	$33.09	267
2019 Q1	53,019,825	$1,857,817,308	+$46,099,024	$12,180,000	$6,885,000	$35.04	281
2018 Q4	51,698,203	$1,717,121,218	-$19,969,207	$9,086,000	$5,987,000	$33.22	265
2018 Q3	51,704,247	$2,602,686,438	-$125,772,976	$14,320,000	$10,790,000	$50.35	282
2018 Q2	53,624,393	$3,206,365,565	+$162,150,149	$29,728,000	$5,182,000	$59.85	317
2018 Q1	51,276,608	$2,344,528,500	+$80,955,651	$6,975,000	$4,905,000	$45.8	308
2017 Q4	49,688,862	$1,981,355,785	-$48,904,009	$4,778,000	$2,535,000	$39.85	294
2017 Q3	50,838,757	$2,034,247,120	+$109,501,908	$8,632,000	$4,432,000	$40	273
2017 Q2	47,330,397	$2,039,414,220	+$105,035,296	$6,913,000	$10,784,000	$43.1	262
2017 Q1	46,114,534	$1,443,390,915	+$218,131,286	$8,190,000	$8,073,000	$31.3	244
2016 Q4	45,333,093	$1,144,464,006	-$18,622,502	$2,343,000	$1,204,000	$25.25	229
2016 Q3	46,037,041	$1,135,870,536	-$9,181,554	$1,871,000	$1,329,000	$24.73	218
2016 Q2	46,516,239	$947,641,508	+$64,706,175	$2,174,000	$2,946,000	$20.37	210
2016 Q1	44,933,850	$685,195,121	+$7,308,210	$898,000	$2,704,000	$15.25	209
2015 Q4	44,768,531	$602,208,907	-$42,998,885	$1,217,000	$1,219,000	$13.44	205
2015 Q3	46,847,791	$657,293,219	+$62,276,957	$3,020,000	$2,246,000	$14.03	179
2015 Q2	42,547,309	$722,438,662	+$78,289,744	$1,811,000	$2,156,000	$16.98	163
2015 Q1	40,418,381	$488,565,846	+$44,904,974	$1,142,000	$3,130,000	$12.09	116
2014 Q4	37,070,882	$307,725,828	+$10,426,090	$847,000	$1,253,000	$8.3	105
2014 Q3	35,649,698	$309,782,879	-$17,884,207	$724,000	$1,046,000	$8.69	93
2014 Q2	37,124,609	$405,366,758	+$42,350,563	$775,000	$6,236,000	$10.95	87
2014 Q1	33,409,780	$298,611,368	+$21,545,722	$3,803,000	$9,989,000	$8.94	83